Guselkumab
Guselkumab is a pharmaceutical drug with 65 clinical trials. Currently 27 active trials ongoing. Historical success rate of 80.6%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
13
Mid Stage
36
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.8%
25 of 33 finished
24.2%
8 ended early
27
trials recruiting
65
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis
Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
Clinical Trials (65)
GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis
Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 65